Correlation Between BRIM Biotechnology and Information Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and Information Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and Information Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BRIM Biotechnology and Information Technology Total, you can compare the effects of market volatilities on BRIM Biotechnology and Information Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of Information Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and Information Technology.

Diversification Opportunities for BRIM Biotechnology and Information Technology

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BRIM and Information is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and Information Technology Total in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Information Technology and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with Information Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Information Technology has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and Information Technology go up and down completely randomly.

Pair Corralation between BRIM Biotechnology and Information Technology

Assuming the 90 days trading horizon BRIM Biotechnology is expected to under-perform the Information Technology. But the stock apears to be less risky and, when comparing its historical volatility, BRIM Biotechnology is 1.25 times less risky than Information Technology. The stock trades about -0.2 of its potential returns per unit of risk. The Information Technology Total is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  4,280  in Information Technology Total on September 15, 2024 and sell it today you would earn a total of  405.00  from holding Information Technology Total or generate 9.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BRIM Biotechnology  vs.  Information Technology Total

 Performance 
       Timeline  
BRIM Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Information Technology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Information Technology Total are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Information Technology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

BRIM Biotechnology and Information Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BRIM Biotechnology and Information Technology

The main advantage of trading using opposite BRIM Biotechnology and Information Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, Information Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Information Technology will offset losses from the drop in Information Technology's long position.
The idea behind BRIM Biotechnology and Information Technology Total pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements